Income Statement

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]      
Revenues  
Operating Expenses:      
Research and development $ 2,936,252 2,933,199 1,797,045
General and administrative 6,063,439 3,783,941 946,613
Stock-based compensation - general and administrative 986,620 732,151 486,271
Total Operating Expenses 9,986,311 7,449,291 3,229,929
Operating Loss (9,986,311) (7,449,291) (3,229,929)
Other Income (Expense), Net:      
Interest income 806 3,066
Gain (loss) on revaluation of derivative warrant liability 452,147 (838,219) 332,095
Interest expense (850,789) (8,994) (7,500)
Total Other Income (Expense), Net (398,642) (846,407) 327,661
Loss before Income Taxes (10,384,953) (8,295,698) (2,902,268)
Income tax benefit
Net Loss $ (10,384,953) $ (8,295,698) $ (2,902,268)
Net Loss Per Share - Basic and Diluted $ (1.89) $ (2.29) $ (1.37)
Weighted Average Common Shares Outstanding      
Basic and diluted 5,482,494 3,623,208 2,122,363

Source